Carlsmed and the International Spine Study Group Foundation Announce Long-term Partnership
Carlsmed, Inc., a commercial stage medical device technology company, is announcing today that it has partnered with the International Spine Study Group Foundation (ISSGF), the premier study group on adult spinal deformity, to collect data on surgical treatment with personalized interbody devices.
- Carlsmed, Inc., a commercial stage medical device technology company, is announcing today that it has partnered with the International Spine Study Group Foundation (ISSGF), the premier study group on adult spinal deformity, to collect data on surgical treatment with personalized interbody devices.
- Long term outcomes data will be collected to assess the role of aprevo devices in improving patient outcomes and reducing postoperative complications.
- "Our partnership with the ISSGF and the inclusion of aprevo in the Complex Adult Deformity Surgery (CADS) clinical study demonstrates the importance of clinical data collection in the treatment of patients with adult spinal deformity, said Mike Cordonnier, CEO of Carlsmed.
- We are committed to partnering with thought leaders in the mission to collect data and improve outcomes for patients with debilitating spine disorders.